Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells
Emmanuelle Fourmentraux-Neves(Inserm), Anne Caignard(Inserm)
Cited by 21
Related Papers
Classification of current anticancer immunotherapies
|Oncotarget|2014|469
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
|Frontiers in Immunology|2019|95
Mature Cytotoxic CD56bright/CD16 <i>+</i> Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma
|Cancer Research|2013|93
Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
|PLoS ONE|2013|65
CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
|Cancer Immunology Research|2018|65